Could a drug save Newborns' brains after oxygen loss?
NCT ID NCT01732146
First seen Nov 20, 2025 · Last updated Jun 18, 2026 · Updated 36 times
Summary
This study tested whether high doses of erythropoietin, a hormone that boosts red blood cell production, can help prevent long-term brain damage in full-term newborns who suffered oxygen loss at birth. All 120 babies also received standard cooling therapy. The goal was to see if the drug improves survival and reduces problems like developmental delays, vision or hearing loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXIC-ISCHEMIC ENCEPHALOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cochin Hospital
Paris, 75014, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.